Xiaoyang MaAssociateProskauer Rose LLPOrganization ProfileFull ProfileConnectEmail+1-212-969-3637 Professional Biography Xiaoyang Ma is a tax attorney and associate in the tax department in Proskauer Rose's New York City office. More Legal and Business Bylines From Xiaoyang Ma New York City Bar Report Recommends Changes in the Appointment and Assignment Process for Family Court Judges - (Posted On Thursday, January 07, 2021) Extension of FBAR Filing Deadline for Certain Filers: December 2020 - (Posted On Wednesday, December 23, 2020) Extension of FBAR Filing Deadline for Certain Filers in December 2019 - (Posted On Friday, December 27, 2019) Newly Proposed US Tax Regulations Open Possibility of Full Credit Support from Foreign Subsidiaries - (Posted On Saturday, November 24, 2018) Impact of Proposed Regulations under Section 956 on Lending Arrangements Involving U.S. Corporate Borrowers - (Posted On Tuesday, November 13, 2018) Current Legal Analysis Differing Approaches to Earned Wage Access Programs Lead to Regulatory Conflict by: Susan Gross Sholinsky Jury Sides with Penn State in Vintage Trademark Case by: Sara M. Bauer The 2025 Final Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know by: Stephanie Trunk , Shoshana Golden Balancing the Scales: How to Use “Legitimate Interest” to Process Personal Data “Fairly” by: Charles-Albert Helleputte , Claire Murphy Senate Judiciary Subcommittee Holds Back Two Key Patent Reform Bills by: Christopher M. Bruno UPC Court of Appeal Rules on Suspending First Instance Enforcement, Managing Director Liability by: Lisa Nassi Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 21 2024 Third-Party Litigation Funding through a Transatlantic Lens Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Nov 21 2024 AI Patent Eligibility: Processing the USPTO's New Guidance Nov 21 2024 Update of 2024 California Employment Law Cases Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 TSCA 30/30 - December 4, 2024 Print
